AstraZeneca drug receives FDA breakthrough status
July 31, 2017
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Imfinzi, an experimental drug developed by AstraZeneca and MedImmune. The drug is used for the treatment of […]
chat_bubble0 Comment
visibility701 Views
Premier Digital Partners
© 2024 Delaware Business Times
